Objetivo
IN-SENS is an interdisciplinary, cutting-edge European industry-academia collaborative effort for a novel training of scientists in molecular psychiatry with the prospect of discovering the biology of schizophrenia and actively promote drug discovery. Mental illnesses are a major burden to patients, relatives, and public health worldwide. IN-SENS therefore aims to profoundly change the academic-industry research landscape in European psychiatry by an unprecedented, innovative strategy.
The extended intra- and intercellular signalling pathway of disrupted-in-schizophrenia 1 (DISC1), the best characterized gene known to cause schizophrenia and other chronic mental illnesses (CMI), will be used as a molecular Rosetta stone for this purpose. Expected results of IN-SENS include profound training, including clinical psychiatry, industrial, and translational medicine exposure, of a new generation of European ESRs capable of understanding the molecular underpinnings of CMI in academia, industry and other non-academic sectors. ESRs will explore how molecules related to the extended DISC1 pathway translate to the different biochemical, genetic, and neurodevelopmental hypotheses and data proposed so far as being important players in the molecular pathology of CMI. Further, they will play an active role in the generation of new analytical tools and therapeutic agents for the diagnosis and treatment of CMI in close collaboration with the industrial sector.
IN-SENS will have immediate and longterm benefits for the European academic-industry research landscape in psychiatry by fostering scientific creativity and entrepreneurial skills of ESRs, generating novel research networks in Europe, enhancing mutual recognition and introducing novel models and of public-private cooperations. At the end of IN-SENS, exceptionally trained ESRs will be ready to extend these studies in academia and/or the private sector, and be able to move confidently to a fruitful professional career.
Ámbito científico
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health scienceshealth sciencespublic health
- natural sciencesbiological sciencescell biologycell signaling
- medical and health sciencesbasic medicinepathology
- medical and health sciencesclinical medicinepsychiatryschizophrenia
Convocatoria de propuestas
FP7-PEOPLE-2013-ITN
Consulte otros proyectos de esta convocatoria
Régimen de financiación
MC-ITN - Networks for Initial Training (ITN)Coordinador
40225 Dusseldorf
Alemania
Ver en el mapa
Participantes (12)
15782 Santiago De Compostela
Ver en el mapa
6200 MD Maastricht
Ver en el mapa
100 44 Stockholm
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa
EH8 9YL Edinburgh
Ver en el mapa
3400 Klosterneuburg
Ver en el mapa
1008 BA AMSTERDAM
Ver en el mapa
00014 Helsingin Yliopisto
Ver en el mapa
80539 MUNCHEN
Ver en el mapa
SW7 2AZ LONDON
Ver en el mapa
151 85 Sodertaelje
Ver en el mapa
4070 Basel
Ver en el mapa